CIRM Funded Clinical Trials
Sequential same donor αβdepleted-HSCT from an HLA-partially matched donor allowing immunosuppression free kidney transplant
Disease Area:
Anemia, Bone Marrow Transplant and Viral Infection
Trial Sponsor:
Stanford University
Trial Stage:
Phase 1/2
Trial Status:
Launching
Targeted Enrollment:
N/A
